Cambium Bio Ltd (CMB) — Cash Flow Reinvestment Rate

Latest as of December 2023: 0.02x

Cambium Bio Ltd (CMB) has a Cash Flow Reinvestment Rate of 0.02x as of December 2023, reinvesting AU$2.27K (capex AU$2.27K ) from operating cash flow of AU$148.25K. Check CMB cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.02x
(Capex + Investments) / Operating CF

Total Reinvested

AU$2.27K
Capex + Investments

Operating Cash Flow

AU$148.25K
AUD

Capital Expenditures

AU$2.27K
AUD

Cambium Bio Ltd Cash Flow Reinvestment Rate (1999–2021)

Historical reinvestment intensity for Cambium Bio Ltd across 6 annual periods. Explore Cambium Bio Ltd (CMB) long-term investment share to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Cambium Bio Ltd (1999–2021)

Year-by-year capital reinvestment analysis for Cambium Bio Ltd. For live market cap and broader valuation context, see market cap of Cambium Bio Ltd.

Year Reinvestment Rate Total Reinvested (AUD) Operating CF Capex YoY Change
2021 0.01x AU$15.57K AU$2.42 Million AU$7.78K ▼ -90.3%
2017 0.07x AU$237.06K AU$3.59 Million AU$149.95K ▼ -98.5%
2002 4.49x AU$24.38 Million AU$5.43 Million AU$6.01 Million ▲ +617.4%
2001 0.63x AU$23.93 Million AU$38.20 Million AU$20.40 Million ▲ +40.1%
2000 0.45x AU$21.58 Million AU$48.26 Million AU$11.95 Million ▼ -49.4%
1999 0.88x AU$29.52 Million AU$33.43 Million AU$18.35 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow